Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight patients lower their weight by 20.7%.
What Is the Ideal Semaglutide Dose for Weight Loss?
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to find out how to calculate.
The most and least expensive weight loss drugs, ranked
Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The medications, which belong to the class of drugs called GLP-1s and were popularized by the diabetes treatment Ozempic,
Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows
Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,
Novo Nordisk’s Wegovy Achieves Weight-Loss of 20.7% at Higher Dose, Study Says
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side-effects.
High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with Zepbound.
Novo Nordisk says higher Wegovy dose caused over 20% weight loss in late-stage trial
Novo Nordisk (NVO) announced Friday that a higher-dose version of its popular obesity therapy, semaglutide, marketed as Wegovy led to 20.7% weight loss over 72 weeks compared to 17.5% weight loss achieved by regular semaglutide in a late-stage trial.
Websites selling compounded weight-loss drugs fail to inform patients of risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Everyday Health11mon
Is It Safe to Use Compounded Semaglutide and Tirzepatide for Weight Loss?
Demand for Ozempic, Wegovy, Zepbound, and Mounjaro has led to the rise of online companies selling what they claim are cheaper versions of the once-a-week injectable medications. But regulation is ...
WDRB1d
Louisville pharmacy dispensing compounded weight loss drugs in effort to address shortage
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Columbus Monthly9d
Tuning Out Food Noise: Semaglutide Injections Help Patients Achieve Long-Term Weight Loss
Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...
Business Insider1y
Shortages of a 'game changer' weight-loss drug are driving people to buy potentially risky knockoff versions
Some versions of compounded semaglutide include additives like B vitamins, which are advertised as further aiding weight loss or reducing common side effects, like nausea. "Those combinations ...
AOL1mon
How Long Can You Take Semaglutide for Weight Loss?
If you’ve been taking Ozempic®, Wegovy®, or a compounded version of semaglutide, you might wonder, How long can you take semaglutide for weight loss? You can take semaglutide for weight ...
USA Today29d
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
a subscription-based weight-loss company that offers compounded semaglutide. Cook said 1 to 2 million Americans take compounded GLP-1 medications, and the vast majority of those patients are ...